◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Ambuja Cements Limited (AMBUJACEM) Revenue 2021–TTM

Name: Ambuja Cements Limited (AMBUJACEM) revenue history 2021-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-11-01

Ambuja Cements Limited annual revenue for fiscal TTM was ₹397.1 billion, a decrease of 0.6% from ₹399.7 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.

AMBUJACEM Annual Revenue

Revenue (annual)	TTM → 2026-09-30	2026-03-31	2025-03-31	2024-03-31	2022-12-31	2021-12-31
Total Revenue	₹397.1B	₹399.7B	₹336.5B	₹325.3B	₹309.8B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AMBUJACEM Quarterly Revenue

Revenue (quarterly)	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹91.7B	₹94.7B	₹108.9B	₹101.8B	₹91.3B	—	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

ULTRACEMCO Revenue — UltraTech Cement Limited
GRASIM Revenue — Grasim Industries Limited
SHREECEM Revenue — Shree Cement Limited
5233 Revenue — Taiheiyo Cement Corporation
JKCEMENT Revenue — J.K. Cement Limited
DALBHARAT Revenue — Dalmia Bharat Limited

More AMBUJACEM metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All AMBUJACEM financial statements → Interactive AMBUJACEM charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.